Wilmington Trust National Association’s AstraZeneca AZN Stock Holding History

Wilmington Trust National Association’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.86M	Buy	24,983 +1,098	+5%	+$79.4K	0.06%	188
2014 Q1	$1.55M	Sell	23,885 -884	-4%	-$57.1K	0.06%	189
2013 Q4	$1.47M	Buy	24,769 +224	+0.9%	+$12.2K	0.05%	195
2013 Q3	$1.27M	Buy	24,545 +2,210	+10%	+$111K	0.05%	204
2013 Q2	$1.06M	Buy	+22,335	New	+$1.14M	0.05%	218

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wilmington Trust National Association's AZN Position: Q2 2014 in Review

Wilmington Trust National Association increased its AstraZeneca (AZN) stake by 4.6% in Q2 2014, buying an estimated $79.4K and bringing the position to 24,983 shares worth $1.86M. The position accounts for 0.06% of the portfolio, ranked #188.

Wilmington Trust National Association first reported a position in AZN in Q2 2013 and has held it in 5 quarters since. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Wilmington Trust National Association held 24,983 shares of AstraZeneca worth $1.86M as of Q2 2014.
Wilmington Trust National Association bought 1,098 AstraZeneca shares in Q2 2014, an estimated $79.4K.
AstraZeneca made up 0.06% of Wilmington Trust National Association's portfolio in Q2 2014, its #188 holding.
Wilmington Trust National Association first reported a position in AstraZeneca in Q2 2013 and has held it in 5 quarters since.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.